SCHEMBL7698484

SCHEMBL7698484

O=C(O)Cc1c(Cc2ccc(Cl)cc2)[nH]c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 2/20 0.54
GAA P10253 1/20 0.54
CASP1 P29466 1/20 0.54
CASP7 P55210 1/20 0.54
EGFR P00533 2/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
HPGD P15428 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
TSHR P16473 2/20 0.52
CYP2C19 P33261 2/20 0.52
MTNR1A P48039 2/20 0.52
MTNR1B P49286 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
CYP2C9 P11712 1/20 0.52
SIRT2 Q8IXJ6 1/20 0.51
SIRT1 Q96EB6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2087168 0.90 HPGD (0.61) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL4262445 0.88 ALDH1A1 (0.55) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL7696486 0.86 ALDH1A1 (0.54) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL8181367 0.86 SIRT2 (0.47) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL4445669 0.86 KDM4E (0.53) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL8178846 0.85 ALDH1A1 (0.47) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL8174978 0.84 ALDH1A1 (0.46) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL7692306 0.83 KDM4E (0.56) MAPTALDH1A1KDM4EGAACASP1
Carbazole SCHEMBL30528371 0.83 KDM4E (0.56) MAPTALDH1A1KDM4EGAACASP1
SCHEMBL8181871 0.82 ALDH1A1 (0.44) MAPTALDH1A1KDM4EGAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002020478-A1 N-BENZYLINDOLE-3-ACETIC ACID DERIVATIVES FOR USE IN THE TREATMENT OF DRUG RESISTAN CANCER DUBLIN CITY UNIVERSITY (IE) 2002-03-14 WO disclosed